GMED vs HSIC
Globus Medical vs Henry Schein — AI-powered side-by-side comparison
GMED
Globus Medical
70
Buy
VS
| Metric | GMED | HSIC |
|---|
| AI Score |
70
|
65
|
| Price |
$82.34
|
$88.16
|
| P/E Ratio |
20.74×
|
25.47×
|
| ROE |
11.8%
|
12.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.5%
|
30.3%
|
| Debt / Equity |
0.02×
|
1.21×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
64.2
|
60.6
|
| Beta |
0.954
|
0.806
|
| Expected Upside |
+1.8%
|
+0.7%
|
AI Committee View
Current Innellis committee reasoning for GMED versus HSIC.
GMED leads by 5 points.
GMED scores 70/100 (Buy) versus HSIC at 65/100 (Buy).
GMED Committee View
100% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- EPS growing 221.2% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
HSIC Committee View
75% agreement
4 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth